Novartis AG’s Drug Onbrez Breezhaler Proved More Effective Against COPD than Other Drugs

ZURICH (Reuters) - Novartis' lung drug Onbrez Breezhaler allows patients with a deadly lung disease to breathe more easily than a current mainstay treatment, adding to positive sentiment surrounding the Swiss drugmaker.